With a gain of more than 531% over the last 12 months, shares of Viking Therapeutics (NASDAQ: VKTX) are a hot commodity, to ...

Semaglutide has been on the FDA's shortage list since 2022, which has enabled compounding pharmacies and manufactures to make their own, unapproved versions of the drug. Novo Nordisk in October ...

Zealand Pharma A/S briefly reclaimed its position as this year’s best performer in the Stoxx 600 Health Care Index on Friday, ...

Novo Nordisk A/S (NYSE:NVO) just hit a technical red flag — a Death Cross. Chart created using Benzinga Pro For those ...

Demand for green power in the United States will grow regardless of who is the country's next president, major players in the ...

The pharmaceutical company says data on 10 deaths and more than 100 hospitalizations comes from the FDA’s adverse event reporting database for semaglutide — the key ingredient in Ozempic and Wegovy, ...

Patience will be necessary to see the returns Novo Nordisk's molecule has the potential to secure ... Getting one more green flag shouldn't be too much of a barrier to continue holding or buying more ...

Patience will be necessary to see the returns Novo Nordisk's molecule has the potential ... Getting one more green flag shouldn't be too much of a barrier to continue holding or buying more ...

Novo Nordisk's molecule has the potential to secure ... Getting one more green flag shouldn't be too much of a barrier to continue holding or buying more shares. Alex Carchidi has no position ...